This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Orion Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations by Petri Ahonen in Inhalation Particle Technology
Introduction
Petri Ahonen is a notable inventor based in Koisjärvi, Finland. He has made significant contributions to the field of inhalation particle technology, particularly in the development of innovative medicaments for respiratory disorders. With a total of 2 patents, his work focuses on improving the efficacy and stability of inhalation particles.
Latest Patents
Ahonen's latest patents include groundbreaking advancements in inhalation particles that incorporate a combination of two or more active ingredients. One of his patents details crystalline spherical inhalation particles that possess a narrow particle size distribution, rough surfaces, and enhanced stability. These particles are particularly beneficial for administering combination medicaments, such as an anti-inflammatory agent and a bronchodilator, for the treatment of asthma and other respiratory disorders. Another patent focuses on combination particles that integrate a β2-agonist and a glucocorticosteroid in a predetermined and constant ratio. These particles are also designed to have a narrow particle size distribution and are preferably in the form of spherical crystalline particles with rough surfaces, making them effective for treating asthma and similar conditions.
Career Highlights
Petri Ahonen is associated with Orion Corporation, where he continues to innovate in the field of pharmaceutical technology. His work has been instrumental in advancing inhalation therapies, contributing to better treatment options for patients suffering from respiratory issues.
Collaborations
Ahonen has collaborated with notable colleagues such as Wiwik Watanabe and Esko I Kauppinen, further enhancing the research and development efforts in his field.
Conclusion
Petri Ahonen's contributions to inhalation particle technology represent a significant advancement in the treatment of respiratory disorders. His innovative patents and collaborations highlight his commitment to improving patient care through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile